Galleri® Cancer Screening offered by Nonkulie Dladla, M.D. provides patients in Manhattan, New York a groundbreaking solution for early cancer detection.
Experience the innovative Galleri® Cancer Screening offered by Nonkulie Dladla, M.D., a trusted provider located in New York, New York. This revolutionary multi-cancer early detection test identifies signals associated with over 50 types of cancers through a simple blood draw. This non-invasive cancer screening test detects cancer-specific methylation patterns in circulating cell-free DNA (cfDNA), enabling early detection of cancers, including those that lack standard screening protocols.
With Nonkulie Dladla, M.D., the goal of Galleri® Cancer Screening is to identify cancers early, when treatment is most effective, providing patients in New York–Newark–Bridgeport with life-saving early detection solutions. The test complements existing cancer screening methods, offering an additional layer of security against undiagnosed malignancies.
Experience the future of multi-cancer detection by Nonkulie Dladla, M.D. in New York, New York. Call (917) 764-3051 now and ensure peace of mind with Galleri® Cancer Screening!
Benefits of Galleri® Cancer Screening
Discover the wide-ranging benefits of Galleri® Cancer Screening, available by Nonkulie Dladla, M.D. in Manhattan. Each benefit below highlights how this advanced cancer diagnostic can transform healthcare for patients in New York and surrounding areas:
About Galleri® Cancer Screening
Who is a Candidate?
Patients in New York and surrounding areas are ideal candidates for Galleri® Cancer Screening. This includes:
- Adults aged 50 and older, who are at higher risk for cancer.
- Individuals with a family history of cancer or genetic predispositions.
- Patients seeking a proactive approach to their health, even without symptoms.
- Those ineligible for traditional cancer screenings or concerned about multi-cancer detection.
Procedure Description
With Nonkulie Dladla, M.D., the process is simple and patient-focused:
- Blood Draw: Nonkulie Dladla, M.D. collects a sample for this blood-based cancer test, which is then sent to a specialized lab.
- cfDNA Analysis: The sample is analyzed for methylation patterns associated with cancer, making it a leading method in advanced cancer diagnostics.
- Results Delivery: Patients and their doctors receive results within 10 business days, detailing any detected cancer signals and their potential tissue of origin.
- Next Steps: If a cancer signal is detected, follow-up diagnostic evaluations with Nonkulie Dladla, M.D. are recommended.
Types of Cancers Detected
Galleri® Cancer Screening effectively detects early signals of:
- Pancreatic Cancer: Detects cfDNA signals indicative of pancreatic tumors, providing early pancreatic cancer detection.
- Liver Cancer: Identifies abnormal methylation patterns related to hepatocellular carcinoma.
- Ovarian Cancer: Provides early ovarian cancer screening.
- Lung Cancer: Screens for markers of non-small cell lung cancer.
- Esophageal Cancer: Aids in detecting esophageal adenocarcinoma.
- Colorectal Cancer: Complements existing colonoscopy protocols with early detection capabilities.
Galleri® Cancer Screening FAQs
What is Galleri® Cancer Screening?
Galleri® is a multi-cancer early detection test offered by Nonkulie Dladla, M.D. in New York, New York, that screens for over 50 types of cancers by analyzing cfDNA methylation patterns.
How does the test work?
It detects abnormal DNA patterns shed by tumors into the bloodstream, identifying potential cancer signals.
Is the test safe?
Yes, Galleri® is a simple, non-invasive cancer screening test with no associated risks, available conveniently by Nonkulie Dladla, M.D..
Who should consider this test?
Adults aged 50 or older, individuals with increased cancer risks, or anyone seeking proactive cancer screening in Manhattan.
Does it replace other cancer screenings?
No, Galleri® is designed to complement—not replace—current cancer screening methods.
How accurate is the test?
The test demonstrates high sensitivity and specificity for multiple cancer types, making it a valuable tool in advanced cancer diagnostics.
When will I get results?
Results are typically available within 10 business days.
What happens if a cancer signal is detected?
Nonkulie Dladla, M.D. will recommend further diagnostic evaluations to confirm and locate the cancer.
Protect Your Health with Galleri® Cancer Screening
Early cancer detection is just a call away. Contact Nonkulie Dladla, M.D. in New York, New York, at (917) 764-3051 to book your Galleri® Cancer Screening!
Systems-Based Care That Connects the Dots
At Gramercy Park Longevity & Regenerative Medicine Center in New York, functional medicine isn’t a buzzword; it’s the backbone of how we think. Nonkulie Dladla, M.D. looks at the interplay of systems, not just symptoms, using advanced labs to understand the “why” behind chronic fatigue, inflammation, hormonal shifts, and digestive dysfunction. From gut-brain axis imbalances to adrenal depletion, Nonkulie Dladla, M.D. connects the dots to uncover patterns others miss.
Your care plan at Gramercy Park Longevity & Regenerative Medicine Center isn’t based on assumptions; it’s based on evidence, partnership, and the belief that healing happens when the right questions are asked.
We take a personalized, precision-based approach using integrative therapies that include:
What Gramercy Park Longevity & Regenerative Medicine Center‘s Patients Say
“I’ve been looking for a doctor to address my hormonal energy level! I searched online and was glad to find this practice. I came all the way from Long Island, and it was definitely worth the trip! Dr. Dladla and her administrative team are phenomenal! I highly recommend giving Dr. Dladla a call and visit!”
— Zwehla T.
